The present invention relates to glucopyranosyloxy-substituted aromatic groups of general formula 1 wherein R.sup.1 to R.sup.6 and R.sup.7a, R.sup.7b, R.sup.7c are defined as in claim 1, the tautomers, the stereoisomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids, which have valuable pharmacological properties, particularly an inhibitory effect on the sodium-dependent glucose cotransporter SGLT2, the use thereof for the treatment of diseases, particularly metabolic disorders such as diabetes, and the preparation thereof.